🔔 After the Bell
🎯 Session Review
Tuesday closed in the red across the board, and honestly, the news flow gave investors plenty to chew on. The S&P 500 slipped 0.32% to 7,728.20, the Nasdaq led declines with a 0.60% drop to 26,445.45, and the Dow shed 184 points to land at 53,791.85. Not a disaster, but not a confidence booster either.Tech took the hardest hit today, which tracks given that GOOGL (Alphabet) dropped $13.72 to $343.80 and ONON (On Holding) cratered nearly $8 a share. Meanwhile, SMCI (Super Micro Computer) managed a slight uptick of $0.14, clinging to $31.60 like a life raft in choppy waters.
Treasury yields dipped slightly, with the 10-year settling at 4.68% and the 30-year at 5.24%. The Dollar Index ticked up a hair to 99.81. Bitcoin also softened, sliding to $63,605, down nearly half a percent. No single cataclysm, just a lot of small pressure points adding up.
📊 Today's Market Movers
|
▲ Gainers
|
▼ Losers
|
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🚀 Key Catalysts
A few big headlines shaped sentiment today. Nvidia (NVDA) grabbed attention after reports surfaced that the chipmaker is developing Nemotron 4, a new family of open-source AI models aimed at competing with the best in the field. For a company already dominating AI hardware, this signals an ambition to own more of the AI stack. The market digested it cautiously, which is fair given how high expectations already sit for NVDA.OpenAI's Brad Lightcap officially confirmed his departure after eight years with the company, the latest in an ongoing leadership reshuffling. Lightcap had stepped down from his COO role in April and was working on special projects until now. Leadership instability at a company of OpenAI's profile sends ripples across AI-adjacent equities and adds another layer of uncertainty to a sector that is already navigating rapid change.
Over at Amazon (AMZN), New York City's political fight over delivery worker classification heated up. A city council bill backed by Mayor Mamdani would force major delivery operators to hire couriers directly rather than relying on subcontractors. For AMZN, which runs one of the largest independent delivery networks in the country, this is worth watching closely as it could raise operating costs if it gains broader traction.
The SpaceX IPO Wasn't For You
🎭 Investor Mood
The cannabis sector added some spice to an otherwise subdued day. Curaleaf (CURLF) plans to launch a hostile $272 million takeover bid for Aurora Cannabis (ACB) after Aurora's board repeatedly rebuffed negotiations. Hostile M&A in a sector still finding its footing tells you that consolidation pressure is real, even if valuations remain tricky.
On the brighter side, Formula E locked in a multiyear global streaming deal with Disney Plus and ESPN (DIS), spanning 144 countries starting this December. It is a meaningful content win for Disney as it continues building out its live sports streaming portfolio. Small positive, but in a day full of mixed signals, investors will take it.
🔍 5 Focus Points for Tomorrow
| 🤖 | Watch NVDA closely as Nemotron 4 AI model details continue to emerge and the developer community reacts |
| 📊 | Monitor JAZZ after its $820 million Actio Biosciences deal closes and analysts update price targets |
| 📊 | Track AMZN for any New York City legislative updates on the delivery worker direct-hire bill |
| 🏛️ | Keep an eye on the 10-year Treasury yield hovering at 4.68% as mortgage rate pressure continues to weigh on housing data |
| 📊 | Follow ACB and CURLF as Curaleaf's hostile takeover bid formally launches and Aurora's board responds |
The $15 Gold Fund That Pays Up to $1,152/Month
💸 Bottom Line
Looking ahead, the throughlines from today are worth keeping on your radar. Nvidia's move into open-source AI models is not just a product story, it is a competitive positioning story. If Nemotron 4 gains traction, it could put pressure on other AI model providers while simultaneously deepening NVDA's moat. Watch for any developer community response in the coming days.The Jazz Pharmaceuticals (JAZZ) acquisition of Actio Biosciences for $820 million is a reminder that pharma M&A is alive and well, particularly in rare disease. The deal centers on a lead drug targeting KCNT1 epilepsy, a high-need, underserved space. Biotech investors should note that specialty pharma is still willing to write big checks for differentiated science.
Finally, Norway's sovereign wealth fund disclosing a $1.22 billion stake in SpaceX for the first time is quietly significant. When the world's largest sovereign wealth fund puts its name on a private market position, it validates the asset class and signals growing institutional appetite for late-stage private companies. Keep an eye on how private market valuations respond to that kind of endorsement.
📰 Further Reading
A breakthrough tech backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang could soon be worth more than the stocks of Apple, Microsoft, and Amazon—combined. It's likely the only answer to a $33 trillion problem... but most people don't yet know it exists. A man who has consulted for the Penta...
Click here to see this tech with your own eyes—and learn how you could invest in the companies that own it.This ingenious scheme – hatched in the shadow of the Global Financial Crisis – could come to fruition in the coming weeks. It may turn Elon into a multi-trillionaire while erasing a looming threat one top Trump insider calls "an economic apocalypse."
This is what it means for your money.Whitney Tilson, editor at Stansberry Research, says he has found what he believes is the greatest retirement stock in America today. It sits at the center of the country's two most important industries, including AI, offers substantial dividends, and one famous money manager placed 60% of his multi-...
Get the name and ticker symbol at no cost



